Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tryptase pseudogene 2 (TPSP2)
- Target
- TPSP2
- Molecular classification
- Other
01
Overview
The entry "tryptase pseudogene 2" (TPSP2) does not correspond to any recognized protein-coding gene, receptor, enzyme, or therapeutic target in the current human gene nomenclature, pharmacological literature, or drug discovery databases. Tryptases are a family of trypsin-like serine proteases with established members such as Tryptase beta-2 (TPSB2) and alpha-tryptase (TPSAB1), which are involved in mast cell biology, allergy, and inflammation, but "TPSP2" is not among them. Pseudogenes in this region exist but are not active drug targets or biologically functional in classical regulatory or enzymatic roles in humans.
- Other names
- Mastinmastintryptase beta pseudogeneTPSP2
Beyond the preview
Go deeper on tryptase pseudogene 2 (TPSP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tryptase pseudogene 2 (TPSP2).